PHARMACIELO LTD (PCLO.CA) Forecast, Price Target & Analyst Ratings
TSX-V:PCLO • CA71716K1012
0.055 CAD
-0.01 (-15.38%)
Last: Mar 10, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHARMACIELO LTD (PCLO.CA).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.06 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PCLO.CA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PCLO.CA.
In the previous month the buy percentage consensus was at a similar level.
PCLO.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 5.309M 172.93% | 1.542M -70.96% | 3.967M 157.28% | |
| EBITDA YoY % growth | -8.948M 60.59% | -9.142M -2.17% | -4.156M 54.54% | |
| EBIT YoY % growth | -10.527M 56.06% | -10.556M -0.28% | -5.798M 45.07% | |
| Operating Margin | -198.30% | -684.67% | -146.17% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PHARMACIELO LTD / PCLO.CA Forecast FAQ
Can you provide the analyst count for PHARMACIELO LTD stock?
The number of analysts covering PHARMACIELO LTD (PCLO.CA) is 6.